Chiron to Release Earnings On Wednesday, April 25, 2001; Conference Call/WebCast to Follow.Business Editors EMERYVILLE, Calif.--(BUSINESS WIRE)--April 18, 2001 Chiron Corporation Chiron Corporation was a multinational biotechnology firm based in Emeryville, California that was acquired by Novartis International AG on April 20 2006. It had offices and facilities in eighteen countries on five continents. (Nasdaq:CHIR CHIR Chiricahua National Monument (US National Park Service) ) announced that its first quarter 2001 financial results will be released on Wednesday April 25, 2001 at 4:00 p.m. Eastern Daylight Time (EDT EDT abbr. Eastern Daylight Time EDT Eastern Daylight Time EDT n abbr (US) (= Eastern Daylight Time) → hora de verano de Nueva York EDT ). Forty-five minutes later, at 4:45 p.m. EDT, as part of the Company's efforts to ensure full disclosure to all parties, Chiron will webcast an earnings discussion conference call live on the Company's internet site. The call will be lead by Sean Lance, chairman and chief executive officer. To access the live call or the 3-day archive via the internet, please logon See login. 1. (jargon) logon - login. 2. (networking) logon - In ACF/VTAM, an unformatted session-initiation request for a session between two logical units. to http://www.chiron.com. Please connect to the Company's website at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be needed to hear the webcast. Alternatively, please call 1-888-306-2701 (US) or 706-634-2118 (international). Replay is available approximately 2 hours after the call through 11:59 p.m. EDT, April 27, 2001. To access the replay, please call 1-800-642-1687 (US) or 706-645-9291 (international). The conference ID number is 703686. About Chiron Chiron Corporation, headquartered in Emeryville, California Emeryville is a small city located in Alameda County, California , in the United States. It is located in a corridor between the cities of Berkeley and Oakland, extending to the shore of San Francisco Bay. , is a leading biotechnology company that participates in three global healthcare markets: biopharmaceuticals, vaccines, and blood testing. The company is applying an integrated scientific approach to the development of innovative products for preventing and treating cancer and infection. For more information about Chiron, visit the company's web site at www.chiron.com. This news release contains forward-looking statements that involve risks and uncertainties. A full discussion of the company's operations and financial condition, including factors that may affect its business and future prospects, is contained in documents the company files with the SEC, such as form 10-Q Form 10-Q See 10-Q. and 10-K. These documents identify important factors that could cause the company's actual performance to differ from current expectations, including the outcome of clinical trials, regulatory review, manufacturing capabilities and marketing effectiveness Marketing Effectiveness is the function of improving how marketers go to market with the goal of optimizing their marketing spend to achieve even better results for both the short-term and long-term. Also related to Marketing ROI and Return on Marketing Investment (ROMI). ." |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion